Cantor Fitzgerald Reiterates Overweight on Elevance Health, Maintains $547 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $547.

November 21, 2023 | 3:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on Elevance Health with a price target of $547.
The reiteration of an Overweight rating by a reputable analyst, along with the maintenance of a high price target, suggests a positive outlook for Elevance Health's stock. This could lead to increased investor confidence and a potential short-term uplift in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100